new angiotensin II (AII) antagonist, Avapro (irbesartan)

You'll see a new angiotensin II (AII) antagonist, Avapro(irbesartan)...from Bristol-Myers Squibb and Sanofi Winthrop.

It's the third AII antagonist on the market...after Cozaar(losartan) and Diovan (valsartan).

These are all approved for hypertension...either alone orwith a thiazide diuretic

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote